Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7017332
Reference Type
Journal Article
Title
Folic acid-functionalized zirconium metal-organic frameworks based electrochemical impedance biosensor for the cancer cell detection
Author(s)
Du, L; Chen, Wei; Wang, J; Cai, Wen; Kong, Shu; Wu, C; ,
Year
2019
Is Peer Reviewed?
1
Journal
Sensors and Actuators B: Chemical
ISSN:
0925-4005
EISSN:
1873-3077
Publisher
ELSEVIER SCIENCE SA
Location
LAUSANNE
DOI
10.1016/j.snb.2019.127073
Web of Science Id
WOS:000489529300041
Abstract
The effective capture and sensitive detection of cancer cells are of great significance to the basic research as well as to the clinical diagnosis and therapy. Here we proposed a simple, low-cost, and high-efficient impedance cytosensor based on folic acid-functionalized zirconium metal-organic frameworks (MOF). Folic acid (FA)-functionalized zirconium MOFs (UiO-66) was utilized as the sensitive element due to the high surface area and porosity, in which FA can be effectively modified onto UiO-66 by the coordinative interaction. The successful preparation of FA@UiO-66 nanocomposite was carefully validated by power X-ray diffraction (XRD), Fourier transform infrared (FT-IR) spectra, UV spectra, zeta potential, transmission electron microscope (TEM), and scanning electron microscope (SEM). The obtained electrochemical impedance results indicated that this impedance sensor functionalized with FA@UiO-66 nanocomposite exhibited good analytical performances in a linear range from 1 x 10(2) to 1 x 10(6) cells/mL. The detection limit was calculated to be as low as 90 cells/mL. It also showed good selectivity in distinguishing FAR-rich cancer cells (e.g. HeLa and H1299 cells) and FAR-negative cells (e.g. HEK-293 cells). HeLa cells spiked in blood samples can also be detected with good recovery rates. All the results demonstrated that this simple and universal approach has great potential to develop disposable and portable biosensors and be applied in the early-stage cancer diagnosis.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity